- Filed
- Jan 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Dec 31, 2023 | 77.41M sh |
| Cash And Equivalents | Q3 2024 · Nov 30, 2023 | $230.02M |
| Cash And Equivalents | Q3 2024 · Feb 28, 2023 | $321.08M |
| Current Liabilities | Q3 2024 · Nov 30, 2023 | $115.67M |
| Current Liabilities | Q3 2024 · Feb 28, 2023 | $119.41M |
| Total Liabilities | Q3 2024 · Nov 30, 2023 | $350.75M |
| Total Liabilities | Q3 2024 · Feb 28, 2023 | $429.28M |
| Current Assets | Q3 2024 · Nov 30, 2023 | $272.09M |
| Current Assets | Q3 2024 · Feb 28, 2023 | $365.95M |
| Total Assets | Q3 2024 · Nov 30, 2023 | $785.47M |
| Total Assets | Q3 2024 · Feb 28, 2023 | $903.07M |
| Shares Diluted | Q3 2024 · Nov 30, 2022 | 71.23M sh |
| Shares Diluted | Q3 2024 · Nov 30, 2022 | 70.76M sh |
| Capex | Q3 2024 · Nov 30, 2022 | $1.9M |
| Operating Cash Flow | Q3 2024 · Nov 30, 2022 | −$38.15M |
| Stockholders Equity | Q3 2024 · Nov 30, 2022 | $485.95M |
| Stockholders Equity | Q3 2024 · Aug 31, 2022 | $506.31M |
| Stockholders Equity | Q3 2024 · May 31, 2022 | $534.51M |
| Stockholders Equity | Q3 2024 · Feb 28, 2022 | $855.79M |
| Eps Diluted | Q3 2024 · Nov 30, 2022 | −$0.56 |
| Eps Diluted | Q3 2024 · Nov 30, 2022 | −$6.07 |
| Eps Basic | Q3 2024 · Nov 30, 2022 | −$0.56 |
| Eps Basic | Q3 2024 · Nov 30, 2022 | −$6.07 |
| Sga Expense | Q3 2024 · Nov 30, 2022 | $20.04M |
| Sga Expense | Q3 2024 · Nov 30, 2022 | $61.3M |
| Net Income | Q3 2024 · Nov 30, 2022 | −$39.87M |
| Net Income | Q3 2024 · Nov 30, 2022 | −$429.22M |
| Net Income | Q3 2024 · Aug 31, 2022 | −$46.52M |
| Net Income | Q3 2024 · May 31, 2022 | −$342.82M |
| Operating Income | Q3 2024 · Nov 30, 2022 | −$40.38M |
| Operating Income | Q3 2024 · Nov 30, 2022 | −$432.33M |
| Revenue | Q3 2024 · Nov 30, 2022 | $90.95M |
| Revenue | Q3 2024 · Nov 30, 2022 | $264.12M |